. 2021 Feb 28;109(4):816–828. doi: 10.1002/cpt.2185
© 2021 The Authors. Clinical Pharmacology & Therapeutics © 2021 American Society for Clinical Pharmacology and Therapeutics
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.
Figure 6.
Self‐controlled risk interval design for assessment of vaccine safety.